Terns Pharmaceuticals Files 8-K
Ticker: TERN · Form: 8-K · Filed: Oct 22, 2025 · CIK: 1831363
Sentiment: neutral
Topics: 8-k, regulatory-filing
TL;DR
Terns Pharma filed an 8-K on Oct 22 for events on Oct 21. Check for updates.
AI Summary
Terns Pharmaceuticals, Inc. filed an 8-K on October 22, 2025, reporting on events that occurred on October 21, 2025. The filing pertains to 'Other Events' and 'Financial Statements and Exhibits'. The company is incorporated in Delaware and its principal executive offices are located in Foster City, California.
Why It Matters
This 8-K filing indicates that Terns Pharmaceuticals has made a regulatory submission, which could contain important updates regarding their financial status or other material events.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not inherently indicate significant risk or positive/negative news without further details within the document.
Key Players & Entities
- Terns Pharmaceuticals, Inc. (company) — Registrant
- October 21, 2025 (date) — Earliest event reported
- October 22, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
- Foster City, California (location) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by Terns Pharmaceuticals in this 8-K filing?
The provided text does not specify the 'Other Events', only that it is an item reported in the 8-K.
What is the significance of the 'Financial Statements and Exhibits' being listed as an item in this 8-K?
This indicates that the filing likely includes or references financial information and supporting documents, though the specifics are not detailed in the provided header.
When was Terns Pharmaceuticals, Inc. incorporated?
The filing states the company is incorporated in Delaware, but the date of incorporation is not provided in this excerpt.
What is the SIC code for Terns Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Terns Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for Terns Pharmaceuticals, Inc.?
The SEC file number for Terns Pharmaceuticals, Inc. is 001-39926.
Filing Stats: 450 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-10-21 17:40:22
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value per share TERN Nasdaq Glo
Filing Documents
- d14463d8k.htm (8-K) — 25KB
- d14463dex991.htm (EX-99.1) — 32KB
- 0001193125-25-245404.txt ( ) — 182KB
- tern-20251021.xsd (EX-101.SCH) — 3KB
- tern-20251021_lab.xml (EX-101.LAB) — 19KB
- tern-20251021_pre.xml (EX-101.PRE) — 12KB
- d14463d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, issued by Terns Pharmaceuticals, Inc. on October 21, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TERNS PHARMACEUTICALS, INC. Date: October 21, 2025 By: /s/ Caryn McDowell Caryn McDowell Chief Legal Officer and Corporate Secretary